Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile

被引:60
作者
Abdellatif, Khaled R. A. [1 ,2 ]
Fadaly, Wael A. A. [1 ]
Elshaier, Yaseen A. M. M. [3 ]
Ali, Waleed A. M. [4 ]
Kamel, Gehan M. [5 ]
机构
[1] Beni Suef Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Bani Suwayf, Egypt
[2] Ibn Sina Natl Coll Med Studies, Pharmaceut Sci Dept, Jeddah 21418, Saudi Arabia
[3] Al Azhar Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Assiut 71524, Egypt
[4] Cairo Gen Hosp, Biochem Dept, Cairo, Egypt
[5] Cairo Univ, Fac Vet, Pharmacol Dept, Cairo, Egypt
关键词
Anti-inflammatory; Pyrazole; Lonazolac; Cyclooxygenase-2; inhibitors; CYCLOOXYGENASE INHIBITION; ULCEROGENIC LIABILITY; BIOLOGICAL EVALUATION; AGENTS; CELECOXIB; DESIGN;
D O I
10.1016/j.bioorg.2018.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Twelve new compounds of 1,3,4-trisubstituted-pyrazole derivatives possessing two cyclooxygenase-2 (COX-2) pharmacophoric moieties (SO2Me or/and SO2NH2) 11a-c, 12a-c, 13a-c and 14a-c were designed and synthesized to be evaluated for their COX inhibition, anti-inflammatory activity, ulcerogenic liability. All compounds were more selective for COX-2 isozyme and showed good in vivo anti-inflammatory activity. The bisaminosulphonyl derivatives (14a-c) were the most COX-2 selective compounds (S.I. = 9.87, 9.50 and 9.22 respectively) and showed good anti-inflammatory potency (ED50 = 15.06, 42.51 and 50.43 mu mol/kg respectively) in comparison with celecoxib (COX-2 S.I. = 8.61, ED50 = 82.2 mu mol/kg). Also, compounds 14a-c were less ulcerogenic (ulcer indexes = 2.72-3.72) than ibuprofen (ulcer index = 20.25) and comparable to celecoxib (ulcer index = 2.93). In addition, to explain the preferential (COX-2) inhibitory and selectivity, the designed compounds were subjected to molecular docking studies. It was found that compound 14c with the highest COX-2 activity and selectivity exhibited a binding pattern and interactions similar to that of celecoxib with formation of more hydrogen-bond features. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:568 / 578
页数:11
相关论文
共 25 条
[1]
Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential [J].
Abd El Razik, Heba A. ;
Badr, Mona H. ;
Atta, Attia H. ;
Mouneir, Samar M. ;
Abu-Serie, Marwa M. .
ARCHIV DER PHARMAZIE, 2017, 350 (05)
[2]
3-Methyl-2-phenyl-1-substituted-indole derivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents [J].
Abdellatif, Khaled R. A. ;
Lamie, Phoebe F. ;
Omar, Hany A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (02) :318-324
[3]
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors [J].
Abdellatif, Khaled R. A. ;
Abdelall, Eman K. A. ;
Fadaly, Wael A. A. ;
Kamel, Gehan M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) :406-412
[4]
Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore [J].
Abdellatif, Khaled R. A. ;
Abdelgawad, Mohamed A. ;
Elshemy, Heba A. H. ;
Alsayed, Shahinda S. R. ;
Kamel, Gehan .
ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (11) :1932-1942
[5]
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors [J].
Abdellatif, Khaled R. A. ;
Abdelgawad, Mohamed A. ;
Labib, Madlen B. ;
Zidan, Taha H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) :5787-5791
[6]
1-(4-Methane(amino)sulfonylphenyl)-3-(4-substituted-phenyl)-5-(4-trifluoromethylphenyl)-1H-2-pyrazolines/pyrazoles as potential anti-inflammatory agents [J].
Abdellatif, Khaled R. A. ;
Elshemy, Heba A. H. ;
Azoz, Amany A. .
BIOORGANIC CHEMISTRY, 2015, 63 :13-23
[7]
Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring [J].
Abdellatif, Khaled R. A. ;
Abdelall, Eman K. A. ;
Fadaly, Wael A. A. ;
Kamel, Gehan M. .
MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (06) :2632-2644
[8]
[Anonymous], VERS 2 5 1 4 OPENEYE
[9]
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methy1-4-phenylisoxazole (P6) [J].
Cingolani, Gino ;
Panella, Andrea ;
Perrone, Maria Grazia ;
Vitale, Paola ;
Di Mauro, Giuseppe ;
Fortuna, Cosimo G. ;
Armen, Roger S. ;
Ferorelli, Savina ;
Smith, William L. ;
Scilimati, Antonio .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :661-668
[10]
Fast Rigid Exhaustive Docking (FRED), REC VERS 2 2 5